<p>Expression of (A) glycosaminoglycans visualized by toluidine blue staining, nuclei are counterstained with haematoxylin, (B) collagen type II immunofluorescence, and (C) collagen type X immunohistochemistry (red-brown) during 5 weeks of chondrogenic differentiation of hfMSCs to chondrocytes. The top panel shows a magnification of the pellet cultures at week 1 and week 5 stained by toluidine blue demonstrating the change in cell morphology and the deposition of the extracellular matrix. The insets in panel B show higher magnifications of collagen type II positive chondrocytes.</p
<p>(A) Representative images of chondrocyte pellets on day 21 derived from BM-MSCs and SYN-MSCs (sca...
The aim of this study was to identify the most appropriate time point for the successful chondrogeni...
<p>Histological sections of 3D-bioprinted constructs with hNCs mixed with hBM-MSCs at day 30 (<i>lef...
<p>Cells were cultured in chondrogenic induction medium (A). Cells demonstrated a sulphated extracel...
<p>Pellets, harvested at days 7, 14, 21 and 28 of culture, were stained with Alcian blue and Sirius ...
<p>Under chondrogenic conditions (A), visual assessment revealed similar levels of toluidine blue st...
<p>Pellets derived from BM-MSCs (A, B) and CESCs (C, D) stained with alcian blue (A, C) and toluidin...
<p>To study the changing expression of integrins during chondrogenic differentiation, human mesenchy...
a. Chondrogenic differentiation assays with AGMK1-9T7 cells at p13 and p23. The chondroblasts in thi...
<p>RT-PCR revealed that the expression of type II collagen and aggrecan in Shh transfected cells aft...
<p>Passage (P)1 hMSCs were grown in the presence of TSA (at 6.25 nM) or vehicle DMSO to passage 6. T...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
<p>(A-C) Human chondrocytes were cultured on a positive control substrate (Ctrl), on gelatin gel (g ...
(A, B) Type II collagen immunostaining of HLA-A2- and HLA-A2+ chondrocyte-agarose constructs after 3...
Due to the limited intrinsic healing ability of mature cartilage tissue, stem cell therapies offer t...
<p>(A) Representative images of chondrocyte pellets on day 21 derived from BM-MSCs and SYN-MSCs (sca...
The aim of this study was to identify the most appropriate time point for the successful chondrogeni...
<p>Histological sections of 3D-bioprinted constructs with hNCs mixed with hBM-MSCs at day 30 (<i>lef...
<p>Cells were cultured in chondrogenic induction medium (A). Cells demonstrated a sulphated extracel...
<p>Pellets, harvested at days 7, 14, 21 and 28 of culture, were stained with Alcian blue and Sirius ...
<p>Under chondrogenic conditions (A), visual assessment revealed similar levels of toluidine blue st...
<p>Pellets derived from BM-MSCs (A, B) and CESCs (C, D) stained with alcian blue (A, C) and toluidin...
<p>To study the changing expression of integrins during chondrogenic differentiation, human mesenchy...
a. Chondrogenic differentiation assays with AGMK1-9T7 cells at p13 and p23. The chondroblasts in thi...
<p>RT-PCR revealed that the expression of type II collagen and aggrecan in Shh transfected cells aft...
<p>Passage (P)1 hMSCs were grown in the presence of TSA (at 6.25 nM) or vehicle DMSO to passage 6. T...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
<p>(A-C) Human chondrocytes were cultured on a positive control substrate (Ctrl), on gelatin gel (g ...
(A, B) Type II collagen immunostaining of HLA-A2- and HLA-A2+ chondrocyte-agarose constructs after 3...
Due to the limited intrinsic healing ability of mature cartilage tissue, stem cell therapies offer t...
<p>(A) Representative images of chondrocyte pellets on day 21 derived from BM-MSCs and SYN-MSCs (sca...
The aim of this study was to identify the most appropriate time point for the successful chondrogeni...
<p>Histological sections of 3D-bioprinted constructs with hNCs mixed with hBM-MSCs at day 30 (<i>lef...